Neumora Therapeutics, Inc.

Market Cap

$337M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.63-$0.03 (-1.81%)

Jun 5, 2026

52W High $3.5952W Low $0.73

Company Details

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops n...

CEO

—

IPO Date

Sep 14, 2023

Website

www.neumoratx.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$222M

EPS (Diluted)

Free Cash Flow

-$193M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 7, 2026

FY 2025

Mar 30, 2026

Q4 2025

Mar 30, 2026

Q3 2025

Nov 6, 2025

Q2 2025

Aug 6, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee